Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA
ClinicalTrials.gov study NCT02326974. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib
ClinicalTrials.gov study NCT05599334. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT01048099. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer
ClinicalTrials.gov study NCT03632941. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative
ClinicalTrials.gov study NCT04191499. IPD Sharing: YES. Countries: 28. Publications: 2.
A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC
ClinicalTrials.gov study NCT02771795. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer
ClinicalTrials.gov study NCT02520063. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients
ClinicalTrials.gov study NCT02910219. IPD Sharing: NO. Countries: 1. Publications: 2.
Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer
ClinicalTrials.gov study NCT02692755. IPD Sharing: NO. Countries: 1. Publications: 28.
An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.
ClinicalTrials.gov study NCT02657343. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Local
ClinicalTrials.gov study NCT02924883. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?
ClinicalTrials.gov study NCT02286843. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer
ClinicalTrials.gov study NCT00811135. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer.
ClinicalTrials.gov study NCT00717405. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT00597597. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer
ClinicalTrials.gov study NCT01041404. IPD Sharing: Not stated. Countries: 24. Publications: 4.
A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery
ClinicalTrials.gov study NCT01864746. IPD Sharing: Not stated. Countries: 11. Publications: 9.
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
ClinicalTrials.gov study NCT01125566. IPD Sharing: Not stated. Countries: 38. Publications: 1.
Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation
ClinicalTrials.gov study NCT03318939. IPD Sharing: NO. Countries: 8. Publications: 1.
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
ClinicalTrials.gov study NCT01358877. IPD Sharing: YES. Countries: 42. Publications: 9.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.